STOCK TITAN

Usana Health Sciences Inc SEC Filings

USNA NYSE

Welcome to our dedicated page for Usana Health Sciences SEC filings (Ticker: USNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

USANA Health Sciences, Inc. filings document financial results, management commentary and Regulation FD disclosures for a health and wellness products company. Form 8-K reports cover quarterly and annual results, preliminary sales information, guidance, exhibits and conference-call materials tied to the company’s operating updates.

Proxy and governance filings address director elections, board matters, executive compensation, equity awards and pay-versus-performance disclosure. Other material-event reports document leadership changes, transition agreements and compensatory arrangements, providing formal records of governance and management structure for USANA Health Sciences.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.37%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.42%
Tags
current report

FAQ

How many Usana Health Sciences (USNA) SEC filings are available on StockTitan?

StockTitan tracks 112 SEC filings for Usana Health Sciences (USNA), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Usana Health Sciences (USNA)?

The most recent SEC filing for Usana Health Sciences (USNA) was filed on July 22, 2025.